1096-9896/asset/cover.gif?v=1&s=9d27ae473c5444468836a93370dc054fd0ea594f "The Journal of Pathology")
Invited commentary for He et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J Pathol 2012; DOI: 10.1002/path.4013.
1096-9896/asset/PATH_left.gif?v=1&s=f8845e760fcc5be3e3baa6119dcc01c077e3db22)
1096-9896/asset/PATH_right.gif?v=1&s=86062495907b9532cd169b5a6605dac7fd14f581)
Invited Commentary
You have free access to this content
Live imaging in zebrafish reveals neu(trophil) insight into the metastatic niche†‡
Article first published online: 2 JUL 2012
DOI: 10.1002/path.4051
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Additional Information
How to Cite
Patton, E. E. (2012), Live imaging in zebrafish reveals neu(trophil) insight into the metastatic niche. J. Pathol., 227: 381–384. doi: 10.1002/path.4051
- †
- ‡
No conflicts of interest were declared.
Publication History
- Issue published online: 10 JUL 2012
- Article first published online: 2 JUL 2012
- Accepted manuscript online: 18 MAY 2012 09:17AM EST
- Manuscript Accepted: 11 MAY 2012
- Manuscript Revised: 11 APR 2012
- Manuscript Received: 26 MAR 2012
References
- 1, . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.
- 2. Tracing the origins of metastasis. J Pathol 2011; 223: 195–204.
- 3, , . Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 9: 274–284.
- 4, , . Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 2010; 18: 884–901.
- 5, . The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009; 9: 285–293.
- 6, , . The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol 2011; 21: 139–146.
- 7
- 8, . The zebrafish as a model for cancer. Dis Model Mech 2010; 3: 517–523.
- 9, , , et al. An optical platform for cell tracking in adult zebrafish. Cytometry A 2012; 81: 176–182.
- 10, , , et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008; 2: 183–189.
- 11, . Genetic models of cancer in zebrafish. Int Rev Cell Mol Biol 2008; 271: 1–34.
- 12, , , et al. A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLoS One 2011; 6: e21768.
- 13, . The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc 2007; 2: 2918–2923.
- 14, , . Zebrafish embryo, a tool to study tumor angiogenesis. Int J Dev Biol 2011; 55: 505–509.
- 15, . In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005; 4: 35–44.
- 16, , . Chemical genetic screening in the zebrafish embryo. Nat Protoc 2009; 4: 1422–1432.
- 17, , , et al. Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads. Cell Commun Signal 2010; 8: 11.
- 18, , , et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J Pathol 2012; DOI: 10.1002/path.4013.Direct Link:
- 19, , , et al. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol 2010; 8: e1000562.
- 20, , , et al. Hypoxia-induced metastasis model in embryonic zebrafish. Nat Protoc 2010; 5: 1911–1918.
- 21, , , et al. Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci 2010; 123: 2332–2341.
- 22, . A model 450 million years in the making: zebrafish and vertebrate immunity. Dis Model Mech 2012; 5: 38–47.
- 23, . Is there really a yin and yang to VEGF-targeted therapies? Lancet Oncol 2010; 11: 809–811.
- 24. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007; 6: 273–286.
- 25, . Cancer: the nuances of therapy. Nature 2009; 458: 290–292.
- 26, , , et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 2007; 25: 4722–4729.
- 27, , , et al. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro-oncology 2010; 12: 233–242.
- 28, . Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008; 8: 592–603.
- 29, , , et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009; 15: 220–231.
- 30, , , et al. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 2009; 15: 167–170.
- 31, , , et al. Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci USA 2012; 109: 2491–2496.
- 32, , , et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009; 15: 232–239.
- 33, , , et al. Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy. Proc Natl Acad Sci USA 2007; 104: 17069–17074.
- 34, , , et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 2008; 26: 127–132.
- 35, , , et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007; 447: 1007–1011.
- 36, , , et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 2011; 8: 445–458.